FOLIC ACID tablet

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)

Pieejams no:

American Health Packaging

SNN (starptautisko nepatentēto nosaukumu):

FOLIC ACID

Kompozīcija:

FOLIC ACID 1 mg

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood. Folic acid is contraindicated in patients who have shown previous intolerance to the drug.

Produktu pārskats:

Folic Acid Tablets, USP, 1 mg, are supplied as round, yellow tablets imprinted “AN” and “361” on one side and scored on the other side. They are available as follows: Unit dose packages of 100 (10 x 10) NDC 62584-897-01 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.

Autorizācija statuss:

Abbreviated New Drug Application

Produkta apraksts

FOLIC ACID- FOLIC ACID TABLET
AMERICAN HEALTH PACKAGING
----------
FOLIC ACID TABLETS, USP
8089701/0419
RX ONLY
DESCRIPTION
Folic acid, N-[ _p_-[[(2-amino-4- hydroxy-6-pteridinyl) methyl]-
amino] benzoyl]-Lglutamic
acid, is a B complex vitamin containing a pteridine moiety linked by a
methylene bridge to
_para_-aminobenzoic acid, which is joined by a peptide linkage to
glutamic acid. Conjugates
of folic acid are present in a wide variety of foods, particularly
liver, kidneys, yeast, and
leafy green vegetables. Commercially available folic acid is prepared
synthetically. Folic
acid, USP occurs as a yellow or yellowish-orange crystalline powder
and is very slightly
soluble in water and insoluble in alcohol. Folic acid, USP is readily
soluble in dilute
solutions of alkali hydroxides and carbonates, and solutions of the
drug may be
prepared with the aid of sodium hydroxide or sodium carbonate, thereby
forming the
soluble sodium salt of folic acid (sodium folate). Aqueous solutions
of folic acid are heat
sensitive and rapidly decompose in the presence of light and/or
riboflavin; solutions
should be stored in a cool place protected from light.
The structural formula of folic acid is as follows:
C
H
N
O
M.W. 441.40
Each tablet, for oral administration, contains 1 mg folic acid, USP.
Folic acid tablets, USP 1 mg contain the following inactive
ingredients: lactose
monohydrate, microcrystalline cellulose, sodium starch glycolate and
stearic acid.
CLINICAL PHARMACOLOGY
Folic acid acts on megaloblastic bone marrow to produce a normoblastic
marrow.
In man, an exogenous source of folate is required for nucleoprotein
synthesis and the
maintenance of normal erythropoiesis. Folic acid is the precursor of
tetrahydrofolic acid,
which is involved as a cofactor for transformylation reactions in the
biosynthesis of
purines and thymidylates of nucleic acids. Impairment of thymidylate
synthesis in
patients with folic acid deficiency is thought to account for the
defective
deoxyribonucleic acid (DNA) synthesis that leads to megaloblast
f